IGC Pharma (IGC) Depreciation & Amortization - Total (2010 - 2014)
IGC Pharma (IGC) posted quarterly Depreciation & Amortization - Total of $148889.0 for Q2 2014, little changed year-over-year from $149294.0 in Q2 2013, and down 44.33% quarter-over-quarter from $267462.0 in Q1 2014.
IGC Pharma (IGC) Depreciation & Amortization - Total (2010 - 2014) Analysis & Trends
IGC Pharma (IGC) has reported Depreciation & Amortization - Total for 5 consecutive years, with $148889.0 the latest figure, recorded in Q2 2014.
- In Q2 2014, Depreciation & Amortization - Total changed 0.27% year-over-year to $148889.0; the TTM figure through Mar 2015 stood at $148889.0 (down 79.1% YoY), while the FY2014 annual figure was $712314.0, up 5.7% from the prior year.
- Depreciation & Amortization - Total fell to $148889.0 in Q2 2014 per IGC's latest filing, from $267462.0 in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $827178.0 in Q1 2012 and bottomed at $42360.0 in Q4 2011.
- Historically, Depreciation & Amortization - Total has averaged $195093.4 across 5 years, with a median of $147708.0 in 2013.
- Annual changes were most pronounced in 2011 — Depreciation & Amortization - Total sank 90.82% — and 2012, when it jumped 556.16%.
- IGC Pharma's Depreciation & Amortization - Total stood at $461627.0 in 2010, then plunged by 90.82% to $42360.0 in 2011, then jumped by 218.19% to $134785.0 in 2012, then increased by 9.59% to $147708.0 in 2013, then gained by 0.8% to $148889.0 in 2014.
- Business Quant data shows IGC's Depreciation & Amortization - Total at $148889.0 in Q2 2014, $267462.0 in Q1 2014, and $147708.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 148,889.00 |
| Mar 31, 2014 | 267,462.00 |
| Dec 31, 2013 | 147,708.00 |
| Sep 30, 2013 | 147,850.00 |
| Jun 30, 2013 | 149,294.00 |
| Mar 31, 2013 | 210,413.00 |
| Dec 31, 2012 | 134,785.00 |
| Sep 30, 2012 | 245,125.00 |
| Jun 30, 2012 | 83,594.00 |
| Mar 31, 2012 | 827,178.00 |
| Dec 31, 2011 | 42,360.00 |
| Sep 30, 2011 | 75,621.00 |
| Jun 30, 2011 | 51,244.00 |
| Mar 31, 2011 | 126,064.00 |
| Dec 31, 2010 | 461,627.00 |
| Sep 30, 2010 | 100,930.00 |
| Jun 30, 2010 | 96,444.00 |